CClinicalTrials.gg
CompletedNCT02635555Updated Sep 26, 2022

The Effects of Height and Weight Adjusted Dose of Local Anesthetic.

An interventional study of Phenylephrine in Complications; Cesarean Section and Hypotension, sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Completed at 1 site in Canada. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-26.

Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

At our centre a conventional dose of 12 mg of hyperbaric bupivacaine in combination with a short acting opioid fentanyl (to increase block density) and a long acting opioid morphine (to provide post-operative pain relief ) is used for spinal anesthesia for cesarean section.However, larger doses of local anesthetic drug when used in caesarean section commonly cause low blood pressure and requires drugs (vasopressors) to treat it. In our study the investigators will standardize the doses of both opioids (fentanyl/morphine) and adjust the dose of local anesthetic (bupivacaine) based on the patients height and weight .One of the obvious challenges anesthesiologists face is providing adequate anesthesia to the patient whilst minimizing harmful side effects. Our primary concern is the low blood pressure as an effect of the spinal anesthetic as it is harmful to both mother and the baby. The investigators propose that the extent of surgical anesthetic block, which is dependent on height and weight in our adjusted dose group, will provide adequate anesthesia for surgery and minimise maternal low blood pressure.

Read the detailed description

Study design is prospective, randomized, double blind, placebo controlled.

Patients presenting for elective cesarean section under neuraxial block and meeting inclusion criteria will be randomized to two groups:

Group 1: Fixed dose group: Bupivacaine 12 mg, Fentanyl 15 mcg, Morphine 100 mcg Group 2: Height and weight adjusted bupivacaine dose, fentanyl 15 mcg, morphine 100 mcg Patients are fasted as per Canadian guidelines prior to the procedure. All patients have an IV cannula inserted,baseline vitals recorded and routine blood work checked prior to blockade. Routine monitoring (as per Canadian Anesthesia Society (CAS) guidelines) occur during and after the procedure. This includes pulse oximetry (SpO2), ECG and non-invasive blood pressure (NIBP). NIBP monitoring occurs every two minutes for the first 20 minutes post spinal and every 5 minutes thereafter. Oxygen via Hudson mask or nasal prongs is available if required.

Spinal anesthetic is performed with standard doses of drugs and the level of sensory block is tested with ice. Motor block is tested with Bromage scale just before prepping and draping. Once deemed adequate, surgery begins. During surgery, phenylephrine/ephedrine is given to maintain blood pressure as necessary. After surgery, patients are monitored in a recovery area until fit to be transferred to their rooms. If patient reports extreme discomfort or sharp pain during the surgery,conversion to general anesthetic is as per the discretion of the attending anesthesiologist.

02

Conditions studied

  • Complications; Cesarean Section
  • Hypotension

Browse trials for

03

In context

Hypotension

1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.

This study's enrollment of 160 is above the median of 80 across 675 interventional studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's is the lead sponsor of 309 studies on the registry; 126 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

ASA I and II patients aged 18-40 > 37 weeks gestation

  • Scheduled for an elective c-section under spinal anesthetic
  • Singleton pregnancy
  • Patients height between 150-180cm and with a BMI of \<35
  • Subject understands the study and consents to participate

Exclusion criteria

Exclusion Criteria:

Contraindication to neuraxial blockade

  • Local anesthetic allergy
  • Above or below our defined height and BMI criteria
  • Emergency C-Section
  • Complicated pregnancy including severe toxemia, pregnancy induced hypertension, and placenta previa
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
160 participants (actual)

Study arms

  • Experimental
    Adjusted Spinal Dose

    Patients in this group receive height and weight adjusted dose for spinal anesthesia.During surgery, phenylephrine/ephedrine is given to maintain blood pressure as necessary. Episodes of hypotension will be treated with these vasopressors .

    Drug: Phenylephrine

  • Active comparator
    Standard Spinal Dose

    Patients in this group receive a fixed standard dose for spinal anesthesia. During surgery, phenylephrine/ephedrine is given to maintain blood pressure as necessary. Episodes of hypotension will be treated with these vasopressors .

    Drug: Phenylephrine

Interventions

  • DrugPhenylephrine

    100 mcg of phenylephrine or 5 mg ephedrine given as deemed necessary for treating episodes of hypotension.

    Also known as: Ephedrine

06

What researchers measure

Primary outcomes

  1. Maternal hypotension needing vasopressors.

    Time frame: Until the end of surgery

Secondary outcomes

  1. Time to adequate surgical anesthetic block

    Time frame: 24 hours after the surgery

  2. incidence of nausea, vomiting, pruritus, and respiratory depression

    Time frame: 24 hours after the surgery

  3. conversion to general anesthesia due to block failure

    Time frame: 1 hour

07

Study locations

1 site
  • Victoria Hospital
    London, Ontario N6A 5W9, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02635555
Lead sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Responsible party
Shalini Dhir (Associate Professor, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's) — Principal investigator
First posted
Dec 21, 2015
Start date
Apr 2016
Primary completion
Jun 2019
Completion
Dec 2019
Last update
Sep 26, 2022

Study contacts

Shalini Dhir, FRCPC
principal investigator · Western University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion